Skip to main content
logo
Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
5.36
-0.14 (-2.55%)
At close: Apr 10, 2026, 4:00 PM EDT
5.37
+0.01 (0.19%)
After-hours: Apr 10, 2026, 7:47 PM EDT

Opus Genetics Revenue

In the year 2025, Opus Genetics had annual revenue of $14.20M with 29.15% growth. Opus Genetics had revenue of $3.87M in the quarter ending December 31, 2025, a decrease of -10.16%.

Revenue (ttm)
$14.20M
Revenue Growth
+29.15%
P/S Ratio
26.86
Revenue / Employee
$507,000
Employees
28
Market Cap
381.36M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202514.20M3.20M29.15%
Dec 31, 202410.99M-8.06M-42.30%
Dec 31, 202319.05M-20.80M-52.20%
Dec 31, 202239.85M39.26M6,665.70%
Dec 31, 2021589.00K--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 200875.00K--
Dec 31, 200775.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

IRD News

More News